These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31206244)

  • 21. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
    Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
    Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
    Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
    J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
    Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W
    Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.
    Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J
    PeerJ; 2021; 9():e11481. PubMed ID: 34046266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.
    Smyth EC; Wotherspoon A; Peckitt C; Gonzalez D; Hulkki-Wilson S; Eltahir Z; Fassan M; Rugge M; Valeri N; Okines A; Hewish M; Allum W; Stenning S; Nankivell M; Langley R; Cunningham D
    JAMA Oncol; 2017 Sep; 3(9):1197-1203. PubMed ID: 28241187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
    Pietrantonio F; Miceli R; Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Morano F; Wotherspoon A; Valeri N; Kook MC; An JY; Grabsch HI; Fucà G; Noh SH; Sohn TS; Kim S; Di Bartolomeo M; Cunningham D; Lee J; Cheong JH; Smyth EC
    J Clin Oncol; 2019 Dec; 37(35):3392-3400. PubMed ID: 31513484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric Cancer.
    Grosser B; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Pfarr N; Steiger K; Novotny A; Gaida MM; Schmidt T; Hapfelmeier A; Ott K; Weichert W; Keller G
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32630478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review.
    Bos J; Groen-van Schooten TS; Brugman CP; Jamaludin FS; van Laarhoven HWM; Derks S
    Cancer Treat Rev; 2024 Jun; 127():102737. PubMed ID: 38669788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
    Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
    World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer.
    Pikuła A; Kwietniewska M; Rawicz-Pruszyński K; Ciseł B; Skórzewska M; Gęca K; Franciszkiewicz-Pietrzak K; Kurylcio A; Mielko J; Polkowski WP
    Semin Oncol; 2020; 47(2-3):127-137. PubMed ID: 32402473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Imamura Y; Toihata T; Haraguchi I; Ogata Y; Takamatsu M; Kuchiba A; Tanaka N; Gotoh O; Mori S; Nakashima Y; Oki E; Mori M; Oda Y; Taguchi K; Yamamoto M; Morita M; Yoshida N; Baba H; Mine S; Nunobe S; Sano T; Noda T; Watanabe M
    Int J Cancer; 2021 Mar; 148(5):1260-1275. PubMed ID: 32997798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.
    Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
    Vo QN; Geradts J; Gulley ML; Boudreau DA; Bravo JC; Schneider BG
    J Clin Pathol; 2002 Sep; 55(9):669-75. PubMed ID: 12194996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of neoadjuvant chemotherapy on microsatellite instability in gastric carcinoma].
    Sun XW; Zhan YQ; Li W; Xu L; Li JT; Chen XJ; Zhang RH; Xu DZ
    Ai Zheng; 2006 Dec; 25(12):1493-6. PubMed ID: 17166373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.
    André T; Tougeron D; Piessen G; de la Fouchardière C; Louvet C; Adenis A; Jary M; Tournigand C; Aparicio T; Desrame J; Lièvre A; Garcia-Larnicol ML; Pudlarz T; Cohen R; Memmi S; Vernerey D; Henriques J; Lefevre JH; Svrcek M
    J Clin Oncol; 2023 Jan; 41(2):255-265. PubMed ID: 35969830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.
    Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J
    J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer.
    Kim JW; Cho SY; Chae J; Kim JW; Kim TY; Lee KW; Oh DY; Bang YJ; Im SA
    Cancer Res Treat; 2020 Oct; 52(4):1178-1187. PubMed ID: 32599979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG island methylator phenotype, Helicobacter pylori, Epstein-Barr virus, and microsatellite instability and prognosis in gastric cancer: a systematic review and meta-analysis.
    Zong L; Seto Y
    PLoS One; 2014; 9(1):e86097. PubMed ID: 24475075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma.
    Yashiro M; Inoue T; Nishioka N; Matsuoka T; Boland CR; Hirakawa K
    Ann Surg Oncol; 2009 Oct; 16(10):2926-35. PubMed ID: 19597886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.